68 related articles for article (PubMed ID: 29080312)
1. Highly active antiretroviral therapy and cervical cytologic abnormalities among women with HIV infection in a limited-resource setting.
Ugboaja JO; Oguejiofor CB; Ogelle OM
Int J Gynaecol Obstet; 2018 Feb; 140(2):228-232. PubMed ID: 29080312
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
Sirera G; Videla S; López-Blázquez R; Llatjos M; Tarrats A; Castellà E; Grane N; Tural C; Rey-Joly C; Clotet B
J Antimicrob Chemother; 2008 Jan; 61(1):191-4. PubMed ID: 17977910
[TBL] [Abstract][Full Text] [Related]
3. Cervical screening in HIV-positive women in the East of England: recent CD4 as the predictive risk factor.
Davies O; Rajamanoharan S; Balachandran T
Int J STD AIDS; 2015 Nov; 26(13):945-50. PubMed ID: 25505037
[TBL] [Abstract][Full Text] [Related]
4. Evolution of cervical cytologic changes among HIV-infected women with normal cytology in the HAART era.
Sirera G; Videla S; López-Blázquez R; Llatjos M; Tarrats A; Castellà E; Grane N; Alcalde C; Tural C; Rey-Joly C; Clotet B
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):965-71. PubMed ID: 17725412
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
Fife KH; Wu JW; Squires KE; Watts DH; Andersen JW; Brown DR
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):274-82. PubMed ID: 19387354
[TBL] [Abstract][Full Text] [Related]
7. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
[TBL] [Abstract][Full Text] [Related]
8. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa.
Firnhaber C; Westreich D; Schulze D; Williams S; Siminya M; Michelow P; Levin S; Faesen M; Smith JS
J Int AIDS Soc; 2012 Jun; 15(2):17382. PubMed ID: 22713259
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
10. Cervical Cytology and Herpes Simplex Virus Type-2 Serology Among Human Immune Deficiency Virus Infected Women on Highly Active Antiretroviral Therapy in Enugu, Nigeria.
Osinachi Ogu C; Uwadiegwu Achukwu P; Onubiwe Nkwo P; Ifeoma-Ossy Ogu R; Steven Onwukwe O; Chinonye Azubuike N; Obianuju Onyemelukwe A; Maryjoy Ifeorah I; Uzoamaka MC
Curr HIV Res; 2022; 20(6):463-471. PubMed ID: 36380408
[TBL] [Abstract][Full Text] [Related]
11. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
13. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
[TBL] [Abstract][Full Text] [Related]
14. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
Seyoum A; Ndlovu P; Temesgen Z
AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
[TBL] [Abstract][Full Text] [Related]
15. Effect of HAART on cervical growths.
TreatmentUpdate; 2001 Aug; 13(4):3-4. PubMed ID: 11590978
[No Abstract] [Full Text] [Related]
16. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
17. Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.
Abe OE; Fagbule OF; Olaniyi OO; Adisa AO; Gbolahan OO
Pan Afr Med J; 2021; 38():370. PubMed ID: 34367449
[TBL] [Abstract][Full Text] [Related]
18. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.
Lourenço L; Samji H; Nohpal A; Chau W; Colley G; Lepik K; Barrios R; Lima V; Hogg RS; Montaner J; Kesselring S; Moore DM
HIV Med; 2015 Jul; 16(6):337-45. PubMed ID: 25721157
[TBL] [Abstract][Full Text] [Related]
19. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
20. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
